Rhythm Pharmaceuticals (RYTM) Interest Coverage Ratio (2016 - 2026)

Rhythm Pharmaceuticals (RYTM) has 11 years of Interest Coverage Ratio data on file, last reported at 11.43 in Q1 2026.

• On a quarterly basis, Interest Coverage Ratio fell 31.47% year-over-year to 11.43 in Q1 2026; TTM through Mar 2026 was 9.99, a 16.98% decrease from a year earlier, with the FY2025 full-year figure at 0.5, up 38.24% from the prior year.
• Interest Coverage Ratio for Q1 2026 stood at 11.43, down from 10.2 in the prior quarter.
• Over the last five years, Interest Coverage Ratio for RYTM reached as high as 7.43 in Q3 2024 and fell as low as 29.42 in Q1 2024.
• Historically, Interest Coverage Ratio has averaged 13.0 across 5 years, with a median of 11.43 in 2026.
• Across the five-year window, Interest Coverage Ratio slumped 71.43% in 2024 and soared 70.46% in 2025, its largest moves.
• Year by year, Interest Coverage Ratio stood at 13.98 in 2022, then soared by 35.14% to 9.07 in 2023, then grew by 16.49% to 7.57 in 2024, then slumped by 34.64% to 10.2 in 2025, then slipped by 12.03% to 11.43 in 2026.
• Per Business Quant data, the three most recent Interest Coverage Ratio figures were 11.43 in Q1 2026, 10.2 in Q4 2025, and 11.1 in Q3 2025.